Cargando…

Multilevel clustering approach driven by continuous glucose monitoring data for further classification of type 2 diabetes

INTRODUCTION: Mining knowledge from continuous glucose monitoring (CGM) data to classify highly heterogeneous patients with type 2 diabetes according to their characteristics remains unaddressed. A refined clustering method that retrieves hidden information from CGM data could provide a viable metho...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Rui, Yu, Xia, Lu, Jingyi, Shen, Yun, Lu, Wei, Zhu, Wei, Bao, Yuqian, Li, Hongru, Zhou, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908294/
https://www.ncbi.nlm.nih.gov/pubmed/33627315
http://dx.doi.org/10.1136/bmjdrc-2020-001869
_version_ 1783655679868796928
author Tao, Rui
Yu, Xia
Lu, Jingyi
Shen, Yun
Lu, Wei
Zhu, Wei
Bao, Yuqian
Li, Hongru
Zhou, Jian
author_facet Tao, Rui
Yu, Xia
Lu, Jingyi
Shen, Yun
Lu, Wei
Zhu, Wei
Bao, Yuqian
Li, Hongru
Zhou, Jian
author_sort Tao, Rui
collection PubMed
description INTRODUCTION: Mining knowledge from continuous glucose monitoring (CGM) data to classify highly heterogeneous patients with type 2 diabetes according to their characteristics remains unaddressed. A refined clustering method that retrieves hidden information from CGM data could provide a viable method to identify patients with different degrees of dysglycemia and clinical phenotypes. RESEARCH DESIGN AND METHODS: From Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, we selected 908 patients with type 2 diabetes (18–83 years) who wore blinded CGM sensors (iPro2, Medtronic, California, USA). Participants were clustered based on CGM data during a 24-hour period by our method. The first level extracted the knowledge-based and statistics-based features to describe CGM signals from multiple perspectives. The Fisher score and variables cluster analysis were applied to fuse features into low dimensions at the second level. The third level divided subjects into subgroups with different clinical phenotypes. The four subgroups of patients were determined by clinical phenotypes. RESULTS: Four subgroups of patients with type 2 diabetes with significantly different statistical features and clinical phenotypes were identified by our method. In particular, individuals in cluster 1 were characterized by the lowest glucose level factor and glucose fluctuation factor, and the highest negative glucose factor and C peptide index. By contrast, cluster 2 had the highest glucose level factor and the lowest C peptide index. Cluster 4 was characterized by the greatest degree of glucose fluctuation factor, was the most insulin-sensitive, and had the lowest insulin resistance. Cluster 3 ranked in the middle concerning the CGM-derived metrics and clinical phenotypes compared with those of the other three groups. CONCLUSION: A novel multilevel clustering approach for knowledge mining from CGM data in type 2 diabetes is presented. The results demonstrate that subgroups are adequately distinguished with notable statistical and clinical differences.
format Online
Article
Text
id pubmed-7908294
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-79082942021-03-11 Multilevel clustering approach driven by continuous glucose monitoring data for further classification of type 2 diabetes Tao, Rui Yu, Xia Lu, Jingyi Shen, Yun Lu, Wei Zhu, Wei Bao, Yuqian Li, Hongru Zhou, Jian BMJ Open Diabetes Res Care Emerging Technologies, Pharmacology and Therapeutics INTRODUCTION: Mining knowledge from continuous glucose monitoring (CGM) data to classify highly heterogeneous patients with type 2 diabetes according to their characteristics remains unaddressed. A refined clustering method that retrieves hidden information from CGM data could provide a viable method to identify patients with different degrees of dysglycemia and clinical phenotypes. RESEARCH DESIGN AND METHODS: From Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, we selected 908 patients with type 2 diabetes (18–83 years) who wore blinded CGM sensors (iPro2, Medtronic, California, USA). Participants were clustered based on CGM data during a 24-hour period by our method. The first level extracted the knowledge-based and statistics-based features to describe CGM signals from multiple perspectives. The Fisher score and variables cluster analysis were applied to fuse features into low dimensions at the second level. The third level divided subjects into subgroups with different clinical phenotypes. The four subgroups of patients were determined by clinical phenotypes. RESULTS: Four subgroups of patients with type 2 diabetes with significantly different statistical features and clinical phenotypes were identified by our method. In particular, individuals in cluster 1 were characterized by the lowest glucose level factor and glucose fluctuation factor, and the highest negative glucose factor and C peptide index. By contrast, cluster 2 had the highest glucose level factor and the lowest C peptide index. Cluster 4 was characterized by the greatest degree of glucose fluctuation factor, was the most insulin-sensitive, and had the lowest insulin resistance. Cluster 3 ranked in the middle concerning the CGM-derived metrics and clinical phenotypes compared with those of the other three groups. CONCLUSION: A novel multilevel clustering approach for knowledge mining from CGM data in type 2 diabetes is presented. The results demonstrate that subgroups are adequately distinguished with notable statistical and clinical differences. BMJ Publishing Group 2021-02-24 /pmc/articles/PMC7908294/ /pubmed/33627315 http://dx.doi.org/10.1136/bmjdrc-2020-001869 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Emerging Technologies, Pharmacology and Therapeutics
Tao, Rui
Yu, Xia
Lu, Jingyi
Shen, Yun
Lu, Wei
Zhu, Wei
Bao, Yuqian
Li, Hongru
Zhou, Jian
Multilevel clustering approach driven by continuous glucose monitoring data for further classification of type 2 diabetes
title Multilevel clustering approach driven by continuous glucose monitoring data for further classification of type 2 diabetes
title_full Multilevel clustering approach driven by continuous glucose monitoring data for further classification of type 2 diabetes
title_fullStr Multilevel clustering approach driven by continuous glucose monitoring data for further classification of type 2 diabetes
title_full_unstemmed Multilevel clustering approach driven by continuous glucose monitoring data for further classification of type 2 diabetes
title_short Multilevel clustering approach driven by continuous glucose monitoring data for further classification of type 2 diabetes
title_sort multilevel clustering approach driven by continuous glucose monitoring data for further classification of type 2 diabetes
topic Emerging Technologies, Pharmacology and Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908294/
https://www.ncbi.nlm.nih.gov/pubmed/33627315
http://dx.doi.org/10.1136/bmjdrc-2020-001869
work_keys_str_mv AT taorui multilevelclusteringapproachdrivenbycontinuousglucosemonitoringdataforfurtherclassificationoftype2diabetes
AT yuxia multilevelclusteringapproachdrivenbycontinuousglucosemonitoringdataforfurtherclassificationoftype2diabetes
AT lujingyi multilevelclusteringapproachdrivenbycontinuousglucosemonitoringdataforfurtherclassificationoftype2diabetes
AT shenyun multilevelclusteringapproachdrivenbycontinuousglucosemonitoringdataforfurtherclassificationoftype2diabetes
AT luwei multilevelclusteringapproachdrivenbycontinuousglucosemonitoringdataforfurtherclassificationoftype2diabetes
AT zhuwei multilevelclusteringapproachdrivenbycontinuousglucosemonitoringdataforfurtherclassificationoftype2diabetes
AT baoyuqian multilevelclusteringapproachdrivenbycontinuousglucosemonitoringdataforfurtherclassificationoftype2diabetes
AT lihongru multilevelclusteringapproachdrivenbycontinuousglucosemonitoringdataforfurtherclassificationoftype2diabetes
AT zhoujian multilevelclusteringapproachdrivenbycontinuousglucosemonitoringdataforfurtherclassificationoftype2diabetes